Johnson & Johnson
JNJ · NYSE
$259.36+$5.57 (+2.19%)TodayMarket closed ·
Prev close $253.79
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 1.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q3 FY26 | $2.56 | $2.59 | +1.0% |
| Q2 FY26 | $2.87 | $2.90 | +0.9% |
| Q1 FY26 | $2.69 | $2.70 | +0.3% |
| Q4 FY25 | $2.46 | $2.46 | −0.1% |
| Q3 FY25 | $2.78 | $2.80 | +0.5% |
| Q2 FY25 | $2.71 | $2.77 | +2.3% |
| Q1 FY25 | $2.61 | $2.77 | +6.0% |
| Q4 FY24 | $2.03 | $2.04 | +0.7% |
Earnings calls
- JNJ - Earnings call Q3 2026
- Deutsche Bank 2026 Healthcare Summit
- Morgan Stanley 24th Annual Global Healthcare Conference
- Wells Fargo 21st Annual Healthcare Conference
- Special Call - Johnson & Johnson
- JNJ - Earnings call Q2 2026
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Bernstein 42nd Annual Strategic Decisions Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.